Cargando…

COVID-19 Associated 60-Day Acute VTE Events in Hospitalized Patients Can be Predicted By D-Dimer and Prior VTE but Not By Reticulated Platelets

Detalles Bibliográficos
Autores principales:	Ashraf, Bilal, Jeon-slaughter, Haekyung, Lee, Nicholas C.J., Bat, Taha, Choi, Sung-Hee, Chen, Weina, Thomas, Abey, Ibrahim, Ibrahim F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology. Published by Elsevier Inc. 2022
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665285/ http://dx.doi.org/10.1182/blood-2022-166966

Ejemplares similares

COVID-19 associated Venous Thromboembolism (VTE) burden in Black women: Findings of Veterans Affairs COVID-19 Shared Data
por: Choi, Sung-Hee, et al.
Publicado: (2022)

Biomarkers for Thrombosis in COVID-19: A Role for High Sensitivity Troponin-I and Immature Platelet Fraction?
por: Ashraf, Bilal, et al.
Publicado: (2021)

Comparison of VTE risk scores in guidelines for VTE diagnosis in nonsurgical hospitalized patients with suspected VTE
por: Xiong, Wei, et al.
Publicado: (2023)

Immature Platelets and Disease Severity in Patients Hospitalized with Acute COVID-19 Who Are Vaccinated Against COVID-19
por: Lee, Nicholas C.J., et al.
Publicado: (2021)

Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review
por: van der Wall, Sake J., et al.
Publicado: (2018)

VTE risk assessment in pregnancy
por: Ewins, Karl, et al.
Publicado: (2019)

Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start)
por: Amin, A., et al.
Publicado: (2009)

Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE
por: Ensor, Joie, et al.
Publicado: (2016)

VTE in ICU Patients With COVID-19
por: Moll, Matthew, et al.
Publicado: (2020)

Metabolomic Profile in Venous Thromboembolism (VTE)
por: Franczyk, Beata, et al.
Publicado: (2021)

CLOTTING AND COVID-19: IT IS NOT ALWAYS VTE
por: LINK, STEPHANIE L, et al.
Publicado: (2022)

Analysis of Readmissions Due to VTE—Using Hospital Data to Improve VTE Prophylaxis Compliance: A Quality Improvement Project
por: Hussain, Muzamil Hamid, et al.
Publicado: (2023)

Hokusai-VTE: Edoxaban for the treatment of venous thromboembolism
por: Said, Karim
Publicado: (2013)

Recommendations for VTE Prophylaxis in Medically Ill Patients
por: Skeik, Nedaa, et al.
Publicado: (2020)

Menstruation, anticoagulation, and contraception: VTE and uterine bleeding
por: Samuelson Bannow, Bethany, et al.
Publicado: (2021)

VTE in ICU: Lessons from COVID-19
por: Chu, Xu, et al.
Publicado: (2022)

Extended anticoagulation for VTE: what evidence justifies it?
por: Walia, Anushka, et al.
Publicado: (2023)

UTILITY OF D-DIMER CUT-OFF POINT WITH VTE IN CRITICALLY ILL PATIENTS WITH COVID-19
por: ZHANG, RAINY, et al.
Publicado: (2021)

Protocol for a systematic review of prognostic models for the recurrence of venous thromboembolism (VTE) following treatment for a first unprovoked VTE
por: Ensor, Joie, et al.
Publicado: (2013)

Platelet-Monocyte Aggregates and C-Reactive Protein are Associated with VTE in Older Surgical Patients
por: Shih, Lauren, et al.
Publicado: (2016)

No VTE Recurrence After 1-Year Follow-Up of Hospitalized Patients With COVID-19 and a VTE Event: A Prospective Study
por: Delrue, Maxime, et al.
Publicado: (2022)

Using Clinical Vignettes to Evaluate VTE Protocol Adherence
por: Todoric, Krista, et al.
Publicado: (2012)

Multiple Myeloma: Cast Nephropathy, VTE, and Neurologic Complications
por: Sullivan, Ellen, et al.
Publicado: (2013)

VTE Registry: What Can Be Learned from RIETE?
por: Tzoran, Inna, et al.
Publicado: (2014)

Duration of anticoagulant therapy and VTE recurrence in patients with cancer
por: Khorana, Alok A., et al.
Publicado: (2019)

What’s new in VTE risk and prevention in orthopedic surgery
por: Kahn, Susan R., et al.
Publicado: (2020)

COVID-19 and Risk of VTE in Ethnically Diverse Populations
por: Go, Alan S., et al.
Publicado: (2021)

Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian Cancer
por: Glassman, Deanna, et al.
Publicado: (2022)

FRI428 VTE And Testosterone Therapy: What Is The Risk?
por: Cheatham, Callie, et al.
Publicado: (2023)

Incidence of Symptomatic Venous Thromboembolism (VTE) in 8,885 Elective Total Hip Arthroplasty Patients Receiving Post-operative Aspirin VTE Prophylaxis
por: Coveney, Eamonn I, et al.
Publicado: (2023)

The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification
por: Gibson, C. Michael, et al.
Publicado: (2017)

Sickle Cell Trait: Is There an Increased VTE Risk in Pregnancy and the Postpartum?
por: Pintova, Sofya, et al.
Publicado: (2013)

Effectiveness of ASA for VTE Prophylaxis in Arthroscopic Rotator Cuff Repair
por: Austin, Luke, et al.
Publicado: (2018)

Review of Therapeutic Options for the Prevention of VTE in Total Joint Arthroplasty
por: Etscheidt, Jordan, et al.
Publicado: (2020)

Harmonizing hypercoagulable heterogeneity: Baseline VTE risk in COVID‐19
por: Goshua, George, et al.
Publicado: (2021)

AstraZeneca COVID-19 vaccine: no increased rate of VTE
Publicado: (2021)

"Cancer Survivorship", kutane Toxizitäten und VTE heiß diskutiert
por: Ortner, Petra
Publicado: (2021)

VTE PROPHYLAXIS STRATEGIES WITH ENOXAPARIN DURING THE COVID-19 PANDEMIC
por: MARK NGUYEN, HUAN, et al.
Publicado: (2021)

Venous thromboembolism (VTE) risk assessment completion in psychiatric inpatients
por: Powell, Harriet, et al.
Publicado: (2021)

Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE
por: Jerjes-Sánchez, Carlos, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mi9g6jl70f5u07cru866cvbt14